MARVELD2 and pancreatic neoplasm: This is in alignment with previous studies showing that the TGFβ type 1 inhibitor, EW-7197, reduced tricellulin expression in nasal epithelial cells (40), and that TGFβ activation increased tricellulin expression in pancreatic cancer cells (41).